ORIC PHARMACEUTICALS INC (ORIC) — insider trading
Health Care · NASDAQ
ORIC PHARMACEUTICALS INC (ORIC) has 42 reported SEC Form 4 insider transactions in our data, including 13 open-market sales among the most recent 42 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Heyman Richard A. | Director | Option exercise / conversion (derivative) | 3,500 | — | $0 | Form 4 |
| 2026-10-01 | Heyman Richard A. | Director | Open-market sale | 3,200 | $12.91 | $41.3K | Form 4 |
| 2026-10-01 | Heyman Richard A. | Director | Open-market sale | 3,500 | $12.91 | $45.2K | Form 4 |
| 2026-10-01 | Heyman Richard A. | Director | Option exercise / conversion | 3,500 | $1.60 | $5.6K | Form 4 |
| 2026-09-28 | Piscitelli Dominic | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 13,400 | — | $0 | Form 4 |
| 2026-09-28 | Piscitelli Dominic | Officer (Chief Financial Officer) | Open-market sale | 13,400 | $13.53 | $181.3K | Form 4 |
| 2026-09-28 | Piscitelli Dominic | Officer (Chief Financial Officer) | Option exercise / conversion | 13,400 | $4.36 | $58.4K | Form 4 |
| 2026-09-24 | Piscitelli Dominic | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 600 | — | $0 | Form 4 |
| 2026-09-24 | Piscitelli Dominic | Officer (Chief Financial Officer) | Open-market sale | 500 | $13.51 | $6.8K | Form 4 |
| 2026-09-24 | Piscitelli Dominic | Officer (Chief Financial Officer) | Open-market sale | 100 | $13.50 | $1.4K | Form 4 |
| 2026-09-24 | Piscitelli Dominic | Officer (Chief Financial Officer) | Option exercise / conversion | 600 | $4.36 | $2.6K | Form 4 |
| 2026-08-26 | Piscitelli Dominic | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 25,000 | — | $0 | Form 4 |
| 2026-08-26 | Piscitelli Dominic | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 52,000 | — | $0 | Form 4 |
| 2026-08-26 | Piscitelli Dominic | Officer (Chief Financial Officer) | Open-market sale | 77,000 | $13.69 | $1.05M | Form 4 |
| 2026-08-26 | Piscitelli Dominic | Officer (Chief Financial Officer) | Option exercise / conversion | 25,000 | $6.00 | $150.0K | Form 4 |
| 2026-08-26 | Piscitelli Dominic | Officer (Chief Financial Officer) | Option exercise / conversion | 52,000 | $4.36 | $226.7K | Form 4 |
| 2026-07-24 | Heyman Richard A. | Director | Option exercise / conversion (derivative) | 3,500 | — | $0 | Form 4 |
| 2026-07-24 | Heyman Richard A. | Director | Open-market sale | 6,100 | $12.02 | $73.3K | Form 4 |
| 2026-07-24 | Heyman Richard A. | Director | Open-market sale | 7,000 | $12.02 | $84.1K | Form 4 |
| 2026-07-24 | Heyman Richard A. | Director | Option exercise / conversion | 3,500 | $1.60 | $5.6K | Form 4 |
| 2026-07-06 | Heyman Richard A. | Director | Open-market sale | 300 | $12.00 | $3.6K | Form 4 |
| 2026-02-24 | Piscitelli Dominic | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 52,000 | — | $0 | Form 4 |
| 2026-02-24 | Piscitelli Dominic | Officer (Chief Financial Officer) | Open-market sale | 52,000 | $13.51 | $702.7K | Form 4 |
| 2026-02-24 | Piscitelli Dominic | Officer (Chief Financial Officer) | Option exercise / conversion | 52,000 | $4.36 | $226.7K | Form 4 |
| 2026-01-16 | Heyman Richard A. | Director | Open-market sale | 3,200 | $12.00 | $38.4K | Form 4 |
| 2026-01-16 | Heyman Richard A. | Director | Open-market sale | 3,500 | $12.00 | $42.0K | Form 4 |
| 2026-01-02 | Chacko Jacob | Director, Officer (PRESIDENT AND CEO) | Grant / award / vesting (derivative) | 112,500 | — | $0 | Form 4 |
| 2026-01-02 | Chacko Jacob | Director, Officer (PRESIDENT AND CEO) | Grant / award / vesting (derivative) | 675,000 | — | $0 | Form 4 |
| 2026-01-02 | Multani Pratik S | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 35,500 | — | $0 | Form 4 |
| 2026-01-02 | Multani Pratik S | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 214,000 | — | $0 | Form 4 |
| 2026-01-02 | Piscitelli Dominic | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 34,500 | — | $0 | Form 4 |
| 2026-01-02 | Piscitelli Dominic | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 206,500 | — | $0 | Form 4 |
| 2026-01-02 | Dier Mardi | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-01-02 | Heyman Richard A. | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-01-02 | Hoerter Steven L. | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-01-02 | Kunkel Lori Anne | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-01-02 | You Angie | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2025-12-16 | Multani Pratik S | Officer (Chief Medical Officer) | Open-market sale | 10,720 | $9.06 | $97.1K | Form 4 |
| 2025-12-15 | Multani Pratik S | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 11,333 | — | $0 | Form 4 |
| 2025-12-15 | Multani Pratik S | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 10,000 | — | $0 | Form 4 |
| 2025-12-15 | Multani Pratik S | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 8,000 | — | $0 | Form 4 |
| 2025-12-15 | Multani Pratik S | Officer (Chief Medical Officer) | Option exercise / conversion | 29,333 | — | $0 | Form 4 |
Ask the chat about ORIC's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ORIC PHARMACEUTICALS INC (ORIC).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.